Neutron Energy Spectrum Measurements with a Compact Liquid Scintillation Detector on EAST

A neutron detector based on EJ301 liquid scintillator has been employed at EAST to measure the neutron energy spectrum for D-D fusion plasma. The detector was carefully characterized in different quasi-monoenergetic neutron fields generated by a 4.5 MV Van de Graaff accelerator. In recent experimental campaigns, due to the low neutron yield at EAST, a new shielding device was designed and located as close as possible to the tokamak to enhance the count rate of the spectrometer. The fluence of neutrons and gamma-rays was measured with the liquid neutron spectrometer and was consistent with 3He proportional counter and NaI (Tl) gamma-ray spectrometer measurements. Plasma ion temperature values were deduced from the neutron spectrum in discharges with lower hybrid wave injection and ion cyclotron resonance heating. Scattered neutron spectra were simulated by the Monte Carlo transport Code, and they were well verified by the pulse height measurements at low energies.Comment: 19 pages,10 figures, 1 tabl

SlimPajama-DC: Understanding Data Combinations for LLM Training

This paper aims to understand the impacts of various data combinations (e.g., web text, wikipedia, github, books) on the training of large language models using SlimPajama. SlimPajama is a rigorously deduplicated, multi-source dataset, which has been refined and further deduplicated to 627B tokens from the extensive 1.2T tokens RedPajama dataset contributed by Together. We've termed our research as SlimPajama-DC, an empirical analysis designed to uncover fundamental characteristics and best practices associated with employing SlimPajama in the training of large language models. During our research with SlimPajama, two pivotal observations emerged: (1) Global deduplication vs. local deduplication. We analyze and discuss how global (across different sources of datasets) and local (within the single source of dataset) deduplications affect the performance of trained models. (2) Proportions of high-quality/highly-deduplicated multi-source datasets in the combination. To study this, we construct six configurations of SlimPajama dataset and train individual ones using 1.3B Cerebras-GPT model with Alibi and SwiGLU. Our best configuration outperforms the 1.3B model trained on RedPajama using the same number of training tokens by a significant margin. All our 1.3B models are trained on Cerebras 16$\times$ CS-2 cluster with a total of 80 PFLOP/s in bf16 mixed precision. We further extend our discoveries (such as increasing data diversity is crucial after global deduplication) on a 7B model with large batch-size training. Our models and the separate SlimPajama-DC datasets are available at: https://huggingface.co/MBZUAI-LLM and https://huggingface.co/datasets/cerebras/SlimPajama-627B.Comment: Technical report. Huggingface: https://huggingface.co/MBZUAI-LLM and https://huggingface.co/datasets/cerebras/SlimPajama-627

SPHysics Simulation of Experimental Spillway Hydraulics

In this paper, we use the parallel open source code parallelSPHysics based on the weakly compressible Smoothed Particle Hydrodynamics (WCSPH) approach to study a spillway flow over stepped stairs. SPH is a robust mesh-free particle modelling technique and has great potential in treating the free surfaces in spillway hydraulics. A laboratory experiment is carried out for the different flow discharges and spillway step geometries. The physical model is constructed from a prototype reservoir dam in the practical field. During the experiment, flow discharge over the weir crest, free surface, velocity and pressure profiles along the spillway are measured. In the present SPH study, a straightforward push-paddle model is used to generate the steady inflow discharge in front of the weir. The parallelSPHysics model is first validated by a documented benchmark case of skimming flow over a stepped spillway. Subsequently, it is used to reproduce a laboratory experiment based on a prototype hydraulic dam project located in Qinghai Province, China. The detailed comparisons are made on the pressure profiles on the steps between the SPH results and experimental data. The energy dissipation features of the flows under different flow conditions are also discussed. It is shown that the pressure on the horizontal face of the steps demonstrates an S-shape, while on the vertical face it is negative on the upper part and positive on the lower part. The energy dissipation efficiency of the spillway could reach nearly 80%

Spatiotemporal cluster patterns of hand, foot, and mouth disease at the county level in Mainland China, 2008-2012

Background: Hand, foot, and mouth disease (HFMD) is known to be a highly contagious childhood illness. In recent years, the number of reported cases of HFMD has significantly increased in mainland China. This study aims at the epidemiological features, spatiotemporal patterns of HMFD at the county/district level in mainland China. Methods: Data on reported HFMD cases for each county from 1 January 2008 to 31 December 2012 were obtained from the Chinese Center for Disease Control and Prevention. Cluster analysis, spatial autocorrelation, and retrospective scan methods were used to explore the spatiotemporal patterns of the disease. Results: The annual incidences varied greatly among the counties, ranging from 0 to 74.31‰with the median of 5.42‰ (interquartile range: 1.54‰–13.55‰) during 2008–2012 in mainland China. Counties close to provincial capital cities generally had higher incidences than rural counties. A seasonal distribution was observed between the northern and southern China, of which dual epidemic were shown in southern China and usually only one in northern China. Based on the global and local spatial autocorrelation analysis, we found that the spatial distribution of HFMD was presented a significant clustering pattern for each year (P \u3c 0.001), and hotspots of the disease were mostly distributed in coastal provinces of China. The retrospective scan statistic further identified the dynamics of spatiotemporal clustering areas of the disease, which were mainly distributed in the counties of eastern and southern China, as well as provincial capitals and their surrounding counties. Conclusions: The spatiotemporal clustering areas of the disease identified in this way were relatively stable, and imminent public health planning and resource allocation should be focused within those areas

Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays.

Spatially resolved transcriptomic technologies are promising tools to study complex biological processes such as mammalian embryogenesis. However, the imbalance between resolution, gene capture, and field of view of current methodologies precludes their systematic application to analyze relatively large and three-dimensional mid- and late-gestation embryos. Here, we combined DNA nanoball (DNB)-patterned arrays and in situ RNA capture to create spatial enhanced resolution omics-sequencing (Stereo-seq). We applied Stereo-seq to generate the mouse organogenesis spatiotemporal transcriptomic atlas (MOSTA), which maps with single-cell resolution and high sensitivity the kinetics and directionality of transcriptional variation during mouse organogenesis. We used this information to gain insight into the molecular basis of spatial cell heterogeneity and cell fate specification in developing tissues such as the dorsal midbrain. Our panoramic atlas will facilitate in-depth investigation of longstanding questions concerning normal and abnormal mammalian development.This work is part of the ‘‘SpatioTemporal Omics Consortium’’ (STOC) paper package. A list of STOC members is available at: http://sto-consortium.org. We would like to thank the MOTIC China Group, Rongqin Ke (Huaqiao University, Xiamen, China), Jiazuan Ni (Shenzhen University, Shenzhen, China), Wei Huang (Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China), and Jonathan S. Weissman (Whitehead Institute, Boston, USA) for their help. This work was supported by the grant of Top Ten Foundamental Research Institutes of Shenzhen, the Shenzhen Key Laboratory of Single-Cell Omics (ZDSYS20190902093613831), and the Guangdong Provincial Key Laboratory of Genome Read and Write (2017B030301011); Longqi Liu was supported by the National Natural Science Foundation of China (31900466) and Miguel A. Esteban’s laboratory at the Guangzhou Institutes of Biomedicine and Health by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16030502), National Natural Science Foundation of China (92068106), and the Guangdong Basic and Applied Basic Research Foundation (2021B1515120075).S

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Background: Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing significant sodium retention. We report the long-term effects of treatment with atrasentan on major renal outcomes. Methods: We did this double-blind, randomised, placebo-controlled trial at 689 sites in 41 countries. We enrolled adults aged 18–85 years with type 2 diabetes, estimated glomerular filtration rate (eGFR)25–75 mL/min per 1·73 m 2 of body surface area, and a urine albumin-to-creatinine ratio (UACR)of 300–5000 mg/g who had received maximum labelled or tolerated renin–angiotensin system inhibition for at least 4 weeks. Participants were given atrasentan 0·75 mg orally daily during an enrichment period before random group assignment. Those with a UACR decrease of at least 30% with no substantial fluid retention during the enrichment period (responders)were included in the double-blind treatment period. Responders were randomly assigned to receive either atrasentan 0·75 mg orally daily or placebo. All patients and investigators were masked to treatment assignment. The primary endpoint was a composite of doubling of serum creatinine (sustained for ≥30 days)or end-stage kidney disease (eGFR <15 mL/min per 1·73 m 2 sustained for ≥90 days, chronic dialysis for ≥90 days, kidney transplantation, or death from kidney failure)in the intention-to-treat population of all responders. Safety was assessed in all patients who received at least one dose of their assigned study treatment. The study is registered with ClinicalTrials.gov, number NCT01858532. Findings: Between May 17, 2013, and July 13, 2017, 11 087 patients were screened; 5117 entered the enrichment period, and 4711 completed the enrichment period. Of these, 2648 patients were responders and were randomly assigned to the atrasentan group (n=1325)or placebo group (n=1323). Median follow-up was 2·2 years (IQR 1·4–2·9). 79 (6·0%)of 1325 patients in the atrasentan group and 105 (7·9%)of 1323 in the placebo group had a primary composite renal endpoint event (hazard ratio [HR]0·65 [95% CI 0·49–0·88]; p=0·0047). Fluid retention and anaemia adverse events, which have been previously attributed to endothelin receptor antagonists, were more frequent in the atrasentan group than in the placebo group. Hospital admission for heart failure occurred in 47 (3·5%)of 1325 patients in the atrasentan group and 34 (2·6%)of 1323 patients in the placebo group (HR 1·33 [95% CI 0·85–2·07]; p=0·208). 58 (4·4%)patients in the atrasentan group and 52 (3·9%)in the placebo group died (HR 1·09 [95% CI 0·75–1·59]; p=0·65). Interpretation: Atrasentan reduced the risk of renal events in patients with diabetes and chronic kidney disease who were selected to optimise efficacy and safety. These data support a potential role for selective endothelin receptor antagonists in protecting renal function in patients with type 2 diabetes at high risk of developing end-stage kidney disease. Funding: AbbVie

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead